Abl Bio

Bi-specific antibodies and Antibody-drug Conjugate immunotherapies for oncology and neurodegenerative diseases

placeSeongnam-si, Gyeonggi-do, South Korea calendar_todayFounded 2016 groups93 employees language ablbio.com

Social engagement

Social engagement: 3.2K social following, 10 posts in the last 12 months — top quartile of its industry.

Investor mix

9 investors on record; lead investors include DS, QUAD, Hana Financial Group.

Investor typeCountShare
Venture capital222%
Private equity111%
Bank & private debt111%
Other / undisclosed556%

Recent activity

28 May 2026
Milestone
regulatory
8 Apr 2026
Partnership
Compass Therapeutics
18 Mar 2026
Event
AACR Annual Meeting
Coming soon